date,title,source
Oct-25-18,Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007,GlobeNewswire
Nov-08-18,"Fibrocell to Host Conference Call and Webcast on Tuesday, November 13, 2018 to Discuss Third Quarter 2018 Financial Results and Recent Highlights",GlobeNewswire
Nov-09-18,Intrexon (XON) Reports Narrower-Than-Expected Loss in Q3,Zacks
Nov-13-18,Fibrocell Reports Third Quarter 2018 Financial Results and Recent Highlights,GlobeNewswire
Nov-19-18,"Market Trends Toward New Normal in Fibrocell Science, Sears Hometown and Outlet Stores, Apellis Pharmaceuticals, Sigma Labs, Highpower International, and Nicholas Financial  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Dec-04-18,What Kind Of Shareholders Own Fibrocell Science Inc (NASDAQ:FCSC)?,Simply Wall St.
Dec-11-18,"Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation",GlobeNewswire
Jan-16-19,Fibrocell to Present at Phacilitate Leaders World 2019,GlobeNewswire
Feb-06-19,Fibrocell to Present at 21st Annual BIO CEO & Investor Conference,GlobeNewswire
Mar-20-19,"Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019",GlobeNewswire
Mar-27-19,Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007,GlobeNewswire
Apr-03-19,Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate Directors,GlobeNewswire
